The US Food and Drug Administration (FDA) has approved the first generic versions of the atypical antipsychotic aripiprazole (Abilify, Otsuka Pharmaceutical Co, Ltd) for the treatment of schizophrenia ...

(Reuters) - Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify. Sign up ...

Lannett announced that its subsidiary Silarx has received approval from the Food and Drug Administration (FDA) for Aripiprazole Oral Solution, the generic version of Otsuka’s Abilify. Abilify is an ...

The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole). Generic aripiprazole is an atypical antipsychotic drug approved to treat schizophrenia and ...

Aripiprazole Tablets are indicated for the treatment of schizophrenia and the acute treatment of manic and mixed episodes associated with bipolar I disorder. Lupin has received the Food and Drug ...

Otsuka Pharmaceuticals was dealt a setback yesterday when the FDA approved four generic versions of its best-selling Abilify antipsychotic pill, following an unusual and protracted legal battle.

Bristol-Myers Squibb (BMS) posted a buoyant set of results in the first quarter, although the approval of generics to $8bn blockbuster Abilify in the US muted celebrations. BMS’ revenues rose 6% to ...

One of the potential side effects listed for the antipsychotic Abilify and its generics is an uncontrollable urge to gamble. But the FDA is now saying that does not nearly encompass the uncontrolled ...